TITLE

Novo Nordisk Payout Rising At Fast Pace

AUTHOR(S)
JUAN CARLOS ARANCIBIA
PUB. DATE
May 2013
SOURCE
Investors Business Daily;5/15/2013, pB10
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
Drugmaker
ACCESSION #
87595440

 

Related Articles

  • PRANDIMET 1mg/500mg.  // Nurse Practitioners Prescribing Reference;Summer2009, Vol. 16 Issue 2, pA.13 

    The article evaluates the Prandimet from Novo Nordisk and Sciele.

  • Novo Nordisk Gears Up to Demerge Two Units. Milmo, Sean // Chemical Market Reporter;09/13/99, Vol. 256 Issue 11, p8 

    Reports the planned demerger of Novo Nordisk's healthcare and industrial enzymes businesses. Stocks owned by Novo Nordisk Foundation at Novo Nordisk; Expectations of the foundation from the move; Posted earnings of Novo Nordisk.

  • Enzyme demand slows in Europe. Milmo, Sean // Chemical Market Reporter;08/24/98, Vol. 254 Issue 8, p10 

    Reports on the decrease in global demand for industrial enzymes in 1998. Novo Nordisk's claim that slowdown was caused by shift from washed blue jeans to darker garments; Sagging demand for enzymes in Asia; Total annual output of washed jeans; Rise in Novo Nordisk's sales of enzymes in the...

  • Dividends Rise But Seen Slowing. JUAN CARLOS ARANCIBIA // Investors Business Daily;12/22/2014, pB15 

    Dividends continue to rise, but the pace of payout growth may slow, a new report says.

  • FAST-ACTING INJECTION OF GLUCAGON.  // Diabetes Health;Dec2014-Jan2015, Vol. 23 Issue 6, p18 

    A chart is presented that lists fast acting injections of glucagon including the GlucaGen HypoKit from Novo Nordisk and the Glucagon injection from Lilly.

  • Modular plants.  // Process Engineering;Nov2002, Vol. 83 Issue 11, p3 

    Announces the contract landed by Emerson Process Management to design a control system for a series of fast track modular pharmaceutical plants for Novo Nordisk Engineering. Provisions under the contract.

  • PRANDIMET 1mg/500mg.  // Physician Assistants' Prescribing Reference;Summer2009, Vol. 16 Issue 2, pA13 

    The article evaluates the antidiabetic tablets, Prandimet from the company Novo Nordisk & Sciele.

  • NEW INDICATIONS.  // Drug Topics;7/9/2007, Vol. 151 Issue 13, p42 

    The article evaluates the Norditropin Injection somatotropin from Novo Nordisk.

  • Living with growth hormone treatment. Norman, Amanda // British Journal of School Nursing;Jun2010, Vol. 5 Issue 5, p258 

    The article reviews the book "Reach for the Stars: Living With Growth," by Novo Nordisk.

  • NovoLog (insulin aspart [rDNA origin] injection) Novo Nordisk.  // Clinician Reviews;Mar2007, Vol. 17 Issue 3, p52 

    The article evaluates the Novolog® insulin aspart injection from Novo Nordisk.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics